Major response to imatinib mesylate in KIT-mutated melanoma
FS Hodi, P Friedlander, CL Corless… - Journal of clinical …, 2008 - pubmed.ncbi.nlm.nih.gov
Major response to imatinib mesylate in KIT-mutated melanoma Major response to imatinib
mesylate in KIT-mutated melanoma J Clin Oncol. 2008 Apr 20;26(12):2046-51. doi: 10.1200/JCO.2007.14.0707.
Authors F Stephen Hodi 1 , Philip Friedlander, Christopher L Corless, Michael C Heinrich,
Suzanne Mac Rae, Andrea Kruse, Jyothi Jagannathan, Annick D Van den Abbeele, Elsa F
Velazquez, George D Demetri, David E Fisher Affiliation 1 The Melanoma Program,
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School …
mesylate in KIT-mutated melanoma J Clin Oncol. 2008 Apr 20;26(12):2046-51. doi: 10.1200/JCO.2007.14.0707.
Authors F Stephen Hodi 1 , Philip Friedlander, Christopher L Corless, Michael C Heinrich,
Suzanne Mac Rae, Andrea Kruse, Jyothi Jagannathan, Annick D Van den Abbeele, Elsa F
Velazquez, George D Demetri, David E Fisher Affiliation 1 The Melanoma Program,
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School …